C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter H—Medical DevicesPart 812—Investigational Device ExemptionsSubpart E—Responsibilities of Investigators

21 C.F.R. § 812.100 (2026)

General responsibilities of investigators

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1996–2016 5citing cases
At a glance

Courts have cited this section in 5 opinions since 1996.

An investigator is responsible for ensuring that an investigation is conducted according to the signed agreement, the investigational plan and applicable FDA regulations, for protecting the rights, safety, and welfare of subjects under the investigator's care, and for the control of devices under investigation. An investigator also is responsible for ensuring that informed consent is obtained in accordance with part 50 of this chapter. Additional responsibilities of investigators are described in subpart G.

[45 FR 3751, Jan. 18, 1980, as amended at 46 FR 8957, Jan. 27, 1981]
The 5 cases that cite 21 C.F.R. § 812.100 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENFemrite v. Abbott Nw. Hosp., 568 N.W.2d 535 (Minn. Ct. App. 1997).
cites § 812.100 2×cited by 17 cases
Where it cites § 812.100
“See 21 C.F.R. § 812.100 (1996) (requiring "investigator" to obtain informed consent).”
Later courts cite it for
“belongs to the class of persons that the regulation is intended to protect,” · 3 citing courts
2
GREENBerish v. Richards Med. Co., 937 F. Supp. 181 (N.D.N.Y. 1996).
cites § 812.100 1×cited by 18 cases
Where it cites § 812.100
“60 (composition and duties of institutional review board); 21 C.F.R. § 812.100 (responsibilities of investigators); 21 C.”
3
GREENMink v. Smith & Nephew, Inc., 169 F. Supp. 3d 1321 (S.D. Fla. 2016).
cites § 812.100 1×cited by 2 cases
Where it cites § 812.100
“Further, 21 C.F.R. § 812.100 requires the investigator, not the manufacturer to obtain the patient’s consent.”
4
GREENBerish v. Richards Med. Co., 928 F. Supp. 185 (N.D.N.Y. 1996).
cites § 812.100 1×cited by 3 cases
Where it cites § 812.100
“60 (composition and duties of institutional review board); 21 C.F.R. § 812.100 (responsibilities of investigators); 21 C.”
5
GREENMink v. Smith & Nephew, Inc., 145 F. Supp. 3d 1208 (S.D. Fla. 2015).
cites § 812.100 1×cited by 1 case
Where it cites § 812.100
“See 21 C.F.R. 812.100. Plaintiff also brings a claim, under Count IV, for negligent misrepresentation based on the notion that S & N represented that it would monitor him through the study for a minimum of ten years.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
199620062016

One bar per year. Tallest: 2 cases in 1996. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
S.D. Fla.2N.D.N.Y.2Minn. Ct. App.1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com